Non-PVC IV bags are intravenous bags made of non-PVC (non-polyvinyl chloride) film. About 25% of all plastic hospital products, including IV bags, are made of a plastic called polyvinyl chloride, or PVC. By itself, PVC is hard and brittle. Most IV bags contain a phthalate called DEHP. Its advantages are the safety and compatibility of drug products.
MARKET DYNAMICS
The non-PVC IV bags market is driving due to the growing reach of the local manufacturers in international market, strict regulations against usage and disposal of PVC, and healthcare infrastructure development in developing countries. Moreover, growing demand for preventive measures against errors, such as delivery of inappropriate dose, and increasing demand for innovative IV containers are some of the principal market drivers.
MARKET SCOPE
The "Non-PVC IV Bags Market Analysis to 2028" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of non-PVC IV bags market with detailed market segmentation by type, material and content type. The non-PVC IV bags market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in non-PVC IV bags market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The non-PVC IV bags market is segmented on the basis of type, material and content type. Based on type, the market is segmented as single chamber and multi chamber. On the basis of material, the market is categorized as ethylene vinyl acetate, polypropylene, co polyester ether and others. On the basis of content type, the market is categorized as frozen mixture and liquid mixture.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the non-PVC IV bags market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The non-PVC IV bags market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting non-PVC IV bags market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the non-PVC IV bags market in these regions.
MARKET PLAYERS
The report covers key developments in the non-PVC IV bags market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from non-PVC IV bags market are anticipated to have lucrative growth opportunities in the future with the rising demand for non-PVC IV bags in the global market. Below mentioned is the list of few companies engaged in the non-PVC IV bags market.
The report also includes the profiles of key players in non-PVC IV bags market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- ANGIPLAST PVT. LTD.
- B. Braun Melsungen AG
- Baxter
- Fresenius Kabi AG
- JW Life Science
- Pfizer, Inc. (Hospira)
- PolyCine GmbH
- RENOLIT
- Shanghai Solve Care Co Ltd.
- Shanghai Xin Gen Eco-Technologies Co., Ltd.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.